NCT05445089View on ClinicalTrials.gov

Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

November 1, 2020

Study Completion Date

December 15, 2020

Conditions

COVID-19COVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Respiratory Distress SyndromeCOVID-19 Lower Respiratory Infection

Interventions

DRUG

Carvacrol

Carvativir 6 mg/ml diluted for oral solution.

OTHER

Control group

Placebo

Trial Locations (1)

1090

Hospital Dr. Leopoldo Manrique Terrero - Periférico de Coche., Caracas

All Listed Sponsors

lead

Instituto Venezolano de Investigaciones Cientificas

OTHER

NCT05445089 - Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients | Biotech Hunter | Biotech Hunter